Yusuf Hamied net worth
Current Net Worth – $2.9 Billion (USD – 290 Crores), (Rupees – 24,280 Crores)
Yusuf Hamied short biography
Net Worth | $2.9 Billion |
---|---|
Born | July 25, 1936 (Age – 87) |
Identified as | Chairman of Cipla |
Status | Indian Scientist |
Education | University of Cambridge, Doctorate |
Nationality | Indian |
Residence | Mumbai, India |
Spousal status | Married |
Children | No |
Yusuf Khwaja Hamied has a net worth of $2.9 Billion (USD – 290 Crores), (Rupees – 24,280 Crores), making him one of the Top 100 Richest men in the world.
He is the non-executive chairman of Cipla, a generic pharmaceuticals firm with a turnover of $2.1 billion founded by his father, a Mahatma Gandhi disciple, Khwaja Abdul Hamied, in 1935.
He is also a member of the Indian National Science Academy, where he has been named as a fellow.
Hamied won the nickname “drug pirate” for taking on major pharmaceutical firms and selling low-cost generic medications for diseases like AIDS.
When the patriarch died in 1972, Hamied, a Cambridge graduate, and his brother Mustafa took over the firm.
Hamied’s net worth was reported to be $1.45 billion by Forbes in January 2016.
You may also like:
Yusuf Hamied biography
Full Name | Yusuf Hamied |
Birthplace | Wilno, Wilno Voivodeship, Poland |
Height | 5.7 feet, 173 cm |
Weight | 95 Kg |
Father | Khwaja Abdul Hamied |
Mother | Luba Derczanska |
Hamied was born on 25 July 1936, in the Lithuanian city of Vilnius.
Luba Derczanska, the son of an Indian Muslim father and a Russophone Lithuanian Jewish mother, met as university students in pre-war Berlin.
Education
Hamied attended Mumbai’s Cathedral and John Connon School, as well as St. Xavier’s College.
In 1954, he moved to England, where he earned a BA in chemistry in 1957 and a Ph.D. from Christ’s College, Cambridge.
Career
As a result of his attempts to eliminate AIDS in the developed world and provide life-saving drugs to patients regardless of their ability to pay, Hamied has been dubbed a modern-day Robin Hood icon.
“I don’t want to make money off these diseases that cause the whole structure of humanity to collapse,” Hamied said.
He was also a pioneer in the creation of multi-drug combination pills, especially for asthma, HIV/AIDS, tuberculosis (TB), and other ailments mainly affecting developed countries, as well as pediatric drug formulations, particularly for children in low-income areas.
Private & early life
Farida is Hamied’s wife, and the couple has no children.
They split their time between London and Mumbai.
His Indian Muslim father and Russophone Lithuanian Jewish mother, Luba Derczanska met in pre-war Berlin when they were university students.
M. K. Hamied, his younger brother, is Cipla’s non-executive vice-chairman. Samina Vaziralli, the latter’s daughter, is likely to take over the leadership of Cipla in the future.
Awards
- In 2005, the Government of India bestowed the Padma Bhushan, India’s third-highest civilian honor to him.
- In 2012, CNN-IBN called Hamied the ‘CNN-IBN Indian of the Year’ in the company category for “making some of the most important medicines more available to the masses in developing countries and taking on global pharma firms.”
- He was also named one of India’s “25 Greatest Global Living Legends” by news channel NDTV in late 2013.
- He was also recently interviewed for the Harvard Business School’s Creating Emerging Markets program, where he discussed his plans to offer AIDS therapies and other medications to vulnerable people in developed countries.
Net worth statistics
- March 2011 – $1.1 B
- March 2012 – $1.1 B
- March 2013 – $1.2 B
- March 2014 – $1.1 B
- March 2015 – $1.8 B
- March 2016 – $1.3 B
- March 2017 – $1.5 B
- March 2018 – $1.7 B
- March 2019 – $1.3 B
- April 2021 – $1.9 B
- April 2022 – $2.3 B
- April 2023 – $1.8 B
- April 2024 – $2.9 B